secwatch.observer — SEC 8-K summary
======================================

Issuer:     Calidi Biotherapeutics, Inc. (CLDI)
CIK:        0001855485
Form:       8-K
Filed at:   2025-02-05T23:59:59+00:00
Accession:  0001493152-25-004887
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Calidi Biotherapeutics ups ATM offering capacity to $11.2M, adds $6.1M
----------------------------------------------------------------------

- Increased maximum ATM offering from $5.1M to $11.2M under existing sales agreement.
- Filed prospectus supplement for $6.1M of common stock; $5.0M already previously sold.
- Move provides additional equity capital for company's ongoing operations.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1855485/000149315225004887/0001493152-25-004887-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1855485/000149315225004887/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-004887

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer